Regulations and Regulatory Advocacy
The Centers for Disease Control and Prevention yesterday updated its guidance to help clinicians evaluate and test patients with relevant history, signs and symptoms for monkeypox
AHA Friday urged lawmakers to consider certain changes to the Verifying Accurate Leading-Edge IVCT Development (VALID) Act.
AHA provides feedback on the Food and Drug Administration
Safety and Landmark Advancements (FDASLA) Act (S.4348).
HHS today withdrew the Trump Administration rule, as advocated by the AHA.
AHA policy staff urged the agency not to finalize the regulation, saying it's unnecessary and would cause confusion.
The association said the OSHA standard is unnecessary and would cause confusion.
The agency said the state has failed to adopt its emergency temporary standard for occupational exposure to COVID-19 and has a history of failing to meet its obligations under the plan.
AHA has urged the agencies to update their merger guidelines.
The Centers for Medicare & Medicaid Services today released a memorandum and provider-specific guidance on complying with the interim final rule.
The Centers for Medicare & Medicaid Services late yesterday issued a proposed rule for the inpatient rehabilitation facility prospective payment system for fiscal year 2023 that would increase payments by 2.8% ($170 million) relative to FY 2021.